• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pulmonary Drug Delivery Technologies - Global Strategic Business Report Product Image

Pulmonary Drug Delivery Technologies - Global Strategic Business Report

  • ID: 338522
  • April 2010
  • Region: Global
  • 599 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in US$ Million by the following Product Segments: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), and Others. The report provides separate comprehensive analytics for US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of the World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 61 companies including many key and niche players such as 3M Drug Delivery Systems Division, Akela Pharma Inc., Alkermes, Inc., Aradigm Corporation, AstraZeneca Plc, Baxter International Inc., Chiesi Farmaceutici SpA, Consort Medical Plc, Dey Pharma L.P., GlaxoSmithKline Plc, Graceway Pharmaceuticals, LLC, NovartiS AG, Oriel Therapeutics, Inc., Sepracor, Inc., SkyePharma Plc, Valois S.A.S, and Vectura Group Plc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

PULMONARY DRUG DELIVERY TECHNOLOGIES

A GLOBAL STRATEGIC BUSINESS REPORT



CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

1. INDUSTRY OVERVIEW

2. PRODUCT OVERVIEW

3. AN OVERVIEW OF PULMONARY CONDITIONS AND THERAPIES

4. PRODUCT INNOVATIONS/INTRODUCTIONS

5. RECENT INDUSTRY ACTIVITY

6. FOCUS ON SELECT PLAYERS

7. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. CANADA

3. JAPAN

4. EUROPE

5. ASIA-PACIFIC

6. LATIN AMERICA

7. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 61 (including Divisions/Subsidiaries - 75)

Region/Country Players

The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Italy
Spain
Rest of Europe
Middle East

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos